Publications

Chen LY, Schirmer U, Widder M, Gruel Y, Rollin J, Zipfel PF, Nguyen TH (2022) Breast cancer cell-based ELISA: a potential material for better detection of heparin-induced thrombocytopenia antibodies. J Mater Chem B [In press]
Halder LD, Babych S, Palme DI, Mansouri-Ghahnavieh E, Ivanov L, Ashonibare V, Langenhorst D, Prusty B, Rambach G, Wich M, Trinks N, Blango MG, Kornitzer D, Terpitz U, Speth C, Jungnickel B, Beyersdorf N, Zipfel PF, Brakhage AA, Skerka C (2022) Candida albicans induces cross-kingdom miRNA trafficking in human monocytes to promote fungal growth. mBio 13(1), e0356321.
Ruiz-Molina N, Parsons J, Müller M, Hoernstein SNW, Bohlender LL, Pumple S, Zipfel PF, Häffner K, Reski R, Decker EL (2022) A synthetic protein as efficient multitarget regulator against complement over-activation Commun Biol [Accepted]
Schieferdecker S, Bernal FA, Wojtas KP, Keiff F, Li Y, Dahse HM, Kloss F (2022) Development of predictive classification models for whole cell antimycobacterial activity of benzothiazinones. J Med Chem 65(9), 6748-6763.
Schmidt T, Afonso S, Perie L, Heidenreich K, Wulf S, Krebs CF, Zipfel PF, Wiech T (2022) An interdisciplinary diagnostic approach to guide therapy in C3 glomerulopathy Frontiers Immunology [In press]
Shahraz A, Lin Y, Mbroh J, Winkler J, Liao H, Lackmann M, Bungartz A, Zipfel PF, Skerka C, Neumann H (2022) Low molecular weight polysialic acid binds to properdin and reduces the activity of the alternative complement pathway Sci Rep [Accepted]
Stea ED, Skerka C, Accetturo M, Pesce F, Wiech T, Hartmann A, Pontrelli P, Castellano G, Zipfel PF, Gesualdo L (2022) Novel FHR2 variants in Atypical Haemolytic Uremic Syndrome: a case study of translational medicine approach in renal transplantation. Frontiers Immunology [In press]
Wendt R, Siwy J, He T, Latosinska A, Wiech T, Zipfel, PF, Tserga A, Vlahou A, Rupprecht H, Catanese L, Mischak H, Beige J (2022) Molecular mapping of urinary complement peptides in kidney diseases. Proteomes 9(4), 49.
Zipfel PF, Skerka C (2022) From Magic Bullets to Modern Therapeutics: Paul Ehrlich, The German Immunobiologist and Physician Who Coined the Term ‘Complement’ Mol Immunol [In press]
Dasari P, Nordengrün M, Vilhena C, Steil L, Abdurrahman G, Surmann K, Dhople V, Lahrberg J, Bachert C, Skerka C, Völker U, Bröker B M, Zipfel P F (2021) The protease SplB of Staphylococcus aureus targets host complement components and inhibits complement-mediated bacterial opsonophagocytosis. J Bacteriol 204(1), e0018421.